Wiadomości giełdowe

Najnowsze wiadomości finansowe · Zaktualizowano Lip 24, 2026

GOOGL
▬ mixed

Czy Alphabet (GOOGL) jest jedną z najlepszych fundamentalnie silnych akcji do kupienia teraz?

Is Alphabet (GOOGL) One of the Best Fundamentally Strong Stocks to Buy Now?

Alphabet's $190B capex commitment for AI infrastructure is a significant risk, as it assumes rapid AI monetization growth. While the …

Yahoo Finance · Maj 17, 2026
MA
▬ mixed

Truist obniża PT dla Mastercard Incorporated (MA)

Truist Lowers PT on Mastercard Incorporated (MA) Stock

The panelists debate Mastercard's (MA) growth prospects, with most expressing concern about decelerating cross-border volumes, high valuation, and regulatory risks …

Yahoo Finance · Maj 17, 2026
▬ mixed

BeInCrypto Institutional Research: 15 Infrastruktur Stablecoinów Napędzających Oferty Krypto

BeInCrypto Institutional Research: 15 Stablecoin Infrastructures Powering Crypto Offerings

The panel discusses the maturation of stablecoin infrastructure, with Gemini and ChatGPT highlighting institutional engagement and bullish sentiment, while Claude …

Yahoo Finance · Maj 17, 2026
LITE
▬ mixed

Dlaczego wszyscy mówią o akcjach Lumentum – i dlaczego inwestorzy powinni się tym zainteresować

Why Everyone Is Talking About Lumentum Stock -- and Why Investors Should Care

Panelists are divided on Lumentum's (LITE) long-term prospects. While they acknowledge the company's impressive revenue growth and the potential of …

Nasdaq · Maj 17, 2026
BA
▼ bear…

Boeing wciąż ma kłopoty z powodu katastrofy Max

Boeing is still in hot water over Max crash

The $49.5M verdict is financially immaterial but prolongs the public reckoning around the 737 MAX crises. The real risk is …

Yahoo Finance · Maj 17, 2026
P S
▬ mixed

Historyk: Dywidendy stanowiły 90% zwrotów do czasu Thrillera Michaela Jacksona, potem wszystko się zmieniło

Historian: Dividends Were 90% of Returns Until Michael Jackson’s Thriller, Then Everything Changed

The panel discusses the shift in S&P 500 returns from dividends to price appreciation, with Gemini and Claude disagreeing on …

Yahoo Finance · Maj 17, 2026
ARM
▬ mixed

Stopy procentowe kredytów hipotecznych i refinansowania dzisiaj, 17 maja 2026 r.: Stopy znacznie wzrosły od poniedziałku

Mortgage and refinance interest rates today, May 17, 2026: Rates way up since Monday

The panel consensus is that the recent jump in mortgage rates, particularly the inversion of the 5/1 ARM, signals a …

Yahoo Finance · Maj 17, 2026
OKLO
▬ mixed

Największa szansa Oklo może być również jej największym problemem

Oklo's Biggest Opportunity Might Also Be Its Biggest Problem

Oklo's valuation is disconnected from near-term cash flows and heavily reliant on future contracts with hyperscalers. The company faces significant …

Nasdaq · Maj 17, 2026
▬ mixed

Amerykanin popełnił błąd oszczędzając na emeryturę. Trudno się od tego podnieść – ale nie jest to niemożliwe

The Average American Made a Retirement Savings Mistake It's Hard to Come Back from -- But Not Impossible

The panel consensus is that the article oversimplifies retirement savings, ignoring key factors like sequence-of-returns risk, wage stagnation, and the …

Nasdaq · Maj 17, 2026
BABA
▬ mixed

Akcje Alibaba mogą być teraz jednym z najbezpieczniejszych sposobów na skorzystanie z boomu AI

Alibaba Stock May Be One of the Safest Ways to Play the AI Boom Right Now

The panel's net takeaway is that Alibaba's AI pivot is overhyped and priced for stagnation, with significant risks from geopolitical …

Nasdaq · Maj 17, 2026
NVTS POET
▬ mixed

Navitas vs. Poet: Który akcyjny fundusz infrastruktury AI jest lepszy do kupienia?

Navitas vs. Poet: Which AI Infrastructure Stock Is the Better Buy?

The panel consensus is bearish on Navitas (NVTS) and Poet (POET), citing high cash-burn rates, dilution risks, and lack of …

Nasdaq · Maj 17, 2026
AZN
▬ mixed

AZN :FDA Zatwierdza ENHERTU dla HER2-dodatniego wczesnego raka piersi w leczeniu neoadjuwantowym i uzupełniającym

AZN :FDA Approves ENHERTU For HER2-Positive Early Breast Cancer In Neoadjuvant And Adjuvant Settings

The FDA approval of ENHERTU in neoadjuvant and adjuvant settings expands AstraZeneca's addressable market but faces significant hurdles, including reimbursement …

Nasdaq · Maj 17, 2026